Mehinto A, Jia A, Snyder S, Jayasinghe B, Denslow N, Crago J, et al. Interlaboratory comparison of in vitro bioassays for screening of endocrine active chemicals in recycled water. Water Res. 2015;83:303-9 pubmed publisher

Ugaonkar S, Clark J, English L, Johnson T, Buckheit K, Bahde R, et al. An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission. J Pharm Sci. 2015;104:3426-39 pubmed publisher

Pennington M, Rivas N, Prager S, Walton W, Trumble J. Pharmaceuticals and personal care products alter the holobiome and development of a medically important mosquito. Environ Pollut. 2015;203:199-207 pubmed publisher

Yuan K, Kang H, Yue Z, Yang L, Lin L, Wang X, et al. Determination of 13 endocrine disrupting chemicals in sediments by gas chromatography-mass spectrometry using subcritical water extraction coupled with dispersed liquid-liquid microextraction and derivatization. Anal Chim Acta. 2015;866:41-7 pubmed publisher

Dubbelman A, Cuyckens F, Dillen L, Gross G, Hankemeier T, Vreeken R. Systematic evaluation of commercially available ultra-high performance liquid chromatography columns for drug metabolite profiling: optimization of chromatographic peak capacity. J Chromatogr A. 2014;1374:122-133 pubmed publisher

Säfholm M, Ribbenstedt A, Fick J, Berg C. Risks of hormonally active pharmaceuticals to amphibians: a growing concern regarding progestagens. Philos Trans R Soc Lond B Biol Sci. 2014;369: pubmed publisher

Zheng N, Dai W, Zhang H, Wang X, Wang J, Zhang X, et al. Lanreotide-conjugated PEG-DSPE micelles: an efficient nanocarrier targeting to somatostatin receptor positive tumors. J Drug Target. 2015;23:67-78 pubmed publisher

Sweeney E, Fan P, Jordan V. Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study. Cancer Res. 2014;74:7060-8 pubmed publisher

Murphy D, Desjardins D, Dereuddre Bosquet N, Brochard P, Perrot L, Pruvost A, et al. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir. J Antimicrob Chemother. 2014;69:2477-88 pubmed publisher

Cooney R, Hayward P. Highlights from the 21st CROI. Lancet Infect Dis. 2014;14:276-7 pubmed

Redd A. Research on hormonal contraception and HIV. Lancet. 2014;383:305 pubmed publisher

GOLLUB E, Stein Z. Research on hormonal contraception and HIV. Lancet. 2014;383:304-5 pubmed publisher

Cates W. Research on hormonal contraception and HIV. Lancet. 2014;383:303-4 pubmed publisher

Kogan P, Wald M. Male contraception: history and development. Urol Clin North Am. 2014;41:145-61 pubmed publisher

Crean C, Tompson D, Buraglio M. The effect of ezogabine on the pharmacokinetics of an oral contraceptive agent. Int J Clin Pharmacol Ther. 2013;51:847-53 pubmed publisher

Archer D, Nakajima S, Sawyer A, Wentworth J, Trupin S, Koltun W, et al. Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive. Obstet Gynecol. 2013;122:601-7 pubmed publisher

Polis C, Curtis K. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis. 2013;13:797-808 pubmed publisher

Ralph L, McCoy S, Hallett T, Padian N. Next steps for research on hormonal contraception and HIV. Lancet. 2013;382:1467-9 pubmed publisher

Africander D, Louw R, Hapgood J. Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy. Biochem Biophys Res Commun. 2013;433:305-10 pubmed publisher

Juvkam K, Gudim H. [Drug induced displacement of menstruation]. Tidsskr Nor Laegeforen. 2013;133:166-8 pubmed publisher

Bush M, Scott R, Watanalumlerd P, Zhi H, Lewis E. Effects of multiple doses of albiglutide on the pharmacokinetics, pharmacodynamics, and safety of digoxin, warfarin, or a low-dose oral contraceptive. Postgrad Med. 2012;124:55-72 pubmed publisher

Polisseni A, Andrade A, Ribeiro L, Castro I, Brandão M, Polisseni F, et al. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study. Maturitas. 2013;74:172-8 pubmed publisher

Roach R, Lijfering W, Helmerhorst F, Cannegieter S, Rosendaal F, Van Hylckama Vlieg A. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy. J Thromb Haemost. 2013;11:124-31 pubmed publisher

Demeestere I, Brice P, Peccatori F, Kentos A, Gaillard I, Zachee P, et al. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. J Clin Oncol. 2013;31:903-9 pubmed publisher

Połać I, Borowiecka M, Wilamowska A, Nowak P. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration. Gynecol Endocrinol. 2013;29:165-8 pubmed publisher

Schneck H, Ruan X, Seeger H, Cahill M, Fehm T, Mueck A, et al. Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. Gynecol Endocrinol. 2013;29:160-3 pubmed publisher

Fetherston S, Geer L, Veazey R, Goldman L, Murphy D, Ketas T, et al. Partial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220. J Antimicrob Chemother. 2013;68:394-403 pubmed publisher

LoRusso P, Piha Paul S, Mita M, Colevas A, Malhi V, Colburn D, et al. Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential. Cancer Chemother Pharmacol. 2013;71:193-202 pubmed publisher

Ferrero S, Leone Roberti Maggiore U, Scala C, Di Luca M, Venturini P, Remorgida V. Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies. Arch Gynecol Obstet. 2013;287:447-53 pubmed publisher

Schierbeck L, Rejnmark L, Tofteng C, Stilgren L, Eiken P, Mosekilde L, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012;345:e6409 pubmed publisher

Brosnan J, Sheppard B, Kelly L, O Leary J, Norris L. Norethisterone acetate alters coagulation gene expression in vitro in human cell culture. Thromb Res. 2013;131:72-7 pubmed publisher

van den Broeck K, Janssens D, Defoort P. A forgotten founding father of the Pill: Ferdinand Peeters, MD. Eur J Contracept Reprod Health Care. 2012;17:321-8 pubmed publisher

Minami T, Kosugi K, Suganuma I, Yamanaka K, Kusuki I, Oyama T, et al. Antiproliferative and apoptotic effects of norethisterone on endometriotic stromal cells in vitro. Eur J Obstet Gynecol Reprod Biol. 2013;166:76-80 pubmed publisher

Vercellini P, Somigliana E, Consonni D, Frattaruolo M, De Giorgi O, Fedele L. Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction. Hum Reprod. 2012;27:3450-9 pubmed publisher

Jonusiene G, Zilaitiene B, Adomaitiene V, Aniuliene R, Bancroft J. Sexual function, mood and menopause symptoms in Lithuanian postmenopausal women. Climacteric. 2013;16:185-93 pubmed publisher

Manassiev N, Godsland I, Proudler A, Whitehead M, Stevenson J. Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism. Clin Endocrinol (Oxf). 2013;78:297-302 pubmed publisher

Kaore S, Langade D, Yadav V, Sharma P, Thawani V, Sharma R. Novel actions of progesterone: what we know today and what will be the scenario in the future?. J Pharm Pharmacol. 2012;64:1040-62 pubmed publisher

Hall K, Trussell J. Types of combined oral contraceptives used by US women. Contraception. 2012;86:659-65 pubmed publisher

Mansour D. Safer prescribing of therapeutic norethisterone for women at risk of venous thromboembolism. J Fam Plann Reprod Health Care. 2012;38:148-9 pubmed publisher

Steward R, Melamed A, Granat A, Mishell D. Comparison of cervical mucus of 24/4 vs. 21/7 combined oral contraceptives. Contraception. 2012;86:710-5 pubmed publisher

Hall K, Trussell J, Schwarz E. Progestin-only contraceptive pill use among women in the United States. Contraception. 2012;86:653-8 pubmed publisher

Cobia D, Smith M, Wang L, Csernansky J. Longitudinal progression of frontal and temporal lobe changes in schizophrenia. Schizophr Res. 2012;139:1-6 pubmed publisher

Koskela Niska V, Lyytinen H, Riska A, Pukkala E, Ylikorkala O. Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study. Climacteric. 2013;16:48-53 pubmed publisher

Chwalisz K, Surrey E, Stanczyk F. The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis. Reprod Sci. 2012;19:563-71 pubmed publisher

Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS Comput Biol. 2011;7:e1002310 pubmed publisher

Ekins S, Williams A, Xu J. A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug Metab Dispos. 2010;38:2302-8 pubmed publisher

Greene N, Fisk L, Naven R, Note R, Patel M, Pelletier D. Developing structure-activity relationships for the prediction of hepatotoxicity. Chem Res Toxicol. 2010;23:1215-22 pubmed publisher

Fourches D, Barnes J, Day N, Bradley P, Reed J, Tropsha A. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 2010;23:171-83 pubmed publisher

Paulen M, Curtis K. When can a woman have repeat progestogen-only injectables--depot medroxyprogesterone acetate or norethisterone enantate?. Contraception. 2009;80:391-408 pubmed publisher

Rajput R, Dhuan J, Agarwal S, Gahlaut P. Central venous sinus thrombosis in a young woman taking norethindrone acetate for dysfunctional uterine bleeding: case report and review of literature. J Obstet Gynaecol Can. 2008;30:680-683 pubmed publisher

Casey C, Murray C. HT update: spotlight on estradiol/norethindrone acetate combination therapy. Clin Interv Aging. 2008;3:9-16 pubmed

Cherkasov A, Ban F, Santos Filho O, Thorsteinson N, Fallahi M, Hammond G. An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin. J Med Chem. 2008;51:2047-56 pubmed publisher

Moda T, Montanari C, Andricopulo A. Hologram QSAR model for the prediction of human oral bioavailability. Bioorg Med Chem. 2007;15:7738-45 pubmed

Draper B, Morroni C, Hoffman M, Smit J, Beksinska M, Hapgood J, et al. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception. Cochrane Database Syst Rev. 2006;:CD005214 pubmed

Lill M, Winiger F, Vedani A, Ernst B. Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals. J Med Chem. 2005;48:5666-74 pubmed

Riis B, Lehmann H, Christiansen C. Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review. Am J Obstet Gynecol. 2002;187:1101-16 pubmed

Maier W, Herman J. Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals. Regul Toxicol Pharmacol. 2001;34:53-61 pubmed

Taitel H, Kafrissen M. Norethindrone--a review of therapeutic applications. Int J Fertil Menopausal Stud. 1995;40:207-23 pubmed

Wiseman L, McTavish D. Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women. Drugs Aging. 1994;4:238-56 pubmed

Brogden R, Speight T, Avery G. Progestagen-only oral contraceptives: a preliminary report of the action and clinical use of norgestrel and norethisterone. Drugs. 1973;6:169-81 pubmed

Stanczyk F, Roy S. Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids. Contraception. 1990;42:67-96 pubmed